Time Restricted Eating (TRE)
Time Restricted Eating (TRE) is a behavioral intervention with 11 clinical trials. Currently 3 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
3
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
TRE: Microbiome, Metabolic Health and Bone
Mapping Metabolic Organ Plasticity in Energy Adaptation
Time Restricted Eating for Weight Loss Maintenance
Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Extended Eating Period
Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
Clinical Trials (11)
TRE: Microbiome, Metabolic Health and Bone
Mapping Metabolic Organ Plasticity in Energy Adaptation
Time Restricted Eating for Weight Loss Maintenance
Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Extended Eating Period
Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)
Family-Based Meal Timing for Cancer Prevention Among Native Hawaiian and Other Pacific Islanders: FAMTIME
Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function in Postmenopausal Women With Overweight and Obesity
Time Restricted Eating and Innate Immunity
A Novel Diet Approach to Combat Gestational Diabetes
All 11 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 11